Mealey's (September 10, 2021, 9:25 AM EDT) -- PHILADELPHIA — A medical provider adequately alleges that it developed a special version of its genetic test predicting reactions to psychiatric drugs in accordance with an insurer’s assurances of payment, only to have the insurer decline to cover the procedure, a federal judge in Pennsylvania said Sept. 1, denying a motion to dismiss....